OMER OMEROS CORP
Healthcare · Pharmaceutical Preparations · Market cap: $1.3B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $65.0K |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $40.5K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $750.9K |
| 2026-Q2 | $0 | $87.1K |
| 2026-Q3 | $0 | $2.2M |
| 2026-Q4 | $0 | $0 |
Bought$40.5K2 buy days
Sold$3.1M15 sell days
Net insider flow-$3.1Mnet selling · 5 years
Latest trade2026-09-23Borges David J.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Sell | Borges David J. | Other C-suite | 10,000 | $20.95 | $209.5K | 1 |
| 2026-09-22 | Sell | Borges David J. | Other C-suite | 10,000 | $20.95 | $209.5K | 1 |
| 2026-08-31 | Sell | Cancelmo Peter B | General counsel | 25,000 | $18.54 | $463.5K | 1 |
| 2026-08-28 | Sell | Cancelmo Peter B | General counsel | 25,000 | $18.65 | $466.1K | 1 |
| 2026-08-27 | Sell | HANISH ARNOLD C | Director | 10,000 | $18.95 | $189.5K | 2 |
| 2026-08-26 | Sell | HANISH ARNOLD C | Director | 5,000 | $18.53 | $92.6K | 1 |
| 2026-08-24 | Sell | Borges David J. | Other C-suite | 906 | $19.10 | $17.3K | 1 |
| 2026-08-21 | Sell | Borges David J. | Other C-suite | 10,000 | $18.95 | $189.5K | 1 |
| 2026-08-20 | Sell | Cable Thomas J. | Director | 15,000 | $18.45 | $276.8K | 1 |
| 2026-08-13 | Sell | Borges David J. | Other C-suite | 5,000 | $16.95 | $84.8K | 1 |
| 2026-05-22 | Sell | Cable Thomas J. | Director | 7,500 | $11.61 | $87.1K | 1 |
| 2026-01-13 | Sell | Borges David J. | Other C-suite | 30,000 | $12.31 | $369.3K | 1 |
| 2026-01-12 | Sell | Borges David J. | Other C-suite | 30,000 | $12.72 | $381.6K | 1 |
| 2023-11-17 | Buy | Demopulos Gregory A MD | CEO | 15,000 | $1.68 | $25.2K | 1 |
| 2023-11-15 | Buy | Demopulos Peter A MD | Director | 10,000 | $1.53 | $15.3K | 1 |
| 2023-05-22 | Sell | Cable Thomas J. | Director | 5,000 | $6.53 | $32.6K | 1 |
| 2023-05-22 | Sell | HANISH ARNOLD C | Director | 5,000 | $6.46 | $32.3K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Borges David J. | Other C-suite | $0 | $1.5M | 2026-09-23 |
| Cancelmo Peter B | General counsel | $0 | $929.7K | 2026-08-31 |
| Cable Thomas J. | Director | $0 | $396.5K | 2026-08-20 |
| HANISH ARNOLD C | Director | $0 | $314.4K | 2026-08-27 |
| Demopulos Gregory A MD | CEO | $25.2K | $0 | 2023-11-17 |
| Demopulos Peter A MD | Director | $15.3K | $0 | 2023-11-15 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.